Articles by Erin Slifka

China Mobile’s plans to list in Shanghai comes after it and domestic rivals China Telecom and China Unicom lost appeals against being delisted from the New York Stock Exchange.

A drug’s nearly two-year journey from a university lab, sped by a partnership with drug giant Merck, is the latest example of the unlikely sources of pandemic antidotes.

The U.S. software company calls Cerner an “anchor asset” for its healthcare ambitions.

Meanwhile, Phillips reports $1.2 billion in sales as major auction houses credit an influx of millennials and first-time buyers with propelling art sales.

A booster dose of Moderna’s Covid-19 vaccine showed signs of working well against the Omicron variant, with the latest lab results suggesting people who are boosted may have good protection against the strain.

The surge is challenging restaurants, manufacturers, hair salons, law firms and others, including some that hope existing precautions will be enough.

The carriers are taking steps to prepare for potential FAA flight restrictions when a new 5G wireless service goes live Jan. 5.

Instead of loosening monetary policy to prop up their economies as they did at the start of the Covid-19 pandemic, central banks are moving to unwind stimulus and raise interest rates.

The latest Spider-Man movie opened to $253 million at the box office this weekend, defying industry expectations.

Manufacturers face backlogged ports, worker shortages and scarce materials and components.